SCHEMBL1376111

SCHEMBL1376111

Fc1c(Cl)c(-c2ccccc2)cc2c(NCC3CCCCC3)n[nH]c12.Fc1c(Cl)c(-c2ccccc2)cc2c(NCCc3ccccc3)n[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.49
CDK1 P06493 2/20 0.49
CDK2 P24941 1/20 0.49
CDC7 O00311 2/20 0.44
AURKB Q96GD4 4/20 0.40
ACHE P22303 1/20 0.40
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
GRM4 Q14833 1/20 0.37
APP P05067 2/20 0.35
GBA1 P04062 1/20 0.35
SOS1 Q07889 1/20 0.35
CRHR1 P34998 2/20 0.34
HIF1A Q16665 1/20 0.33
UTS2R Q9UKP6 1/20 0.33
PLK4 O00444 1/20 0.33
PDPK1 O15530 1/20 0.33
DAPK3 O43293 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2334940 0.93 GSK3B (0.56) GSK3BCDK1CDK2CDC7AURKB
SCHEMBL1376173 0.92 GSK3B (0.57) GSK3BCDK1CDK2CDC7AURKB
SCHEMBL6528308 0.90 GSK3B (0.50) GSK3BCDK1CDK2CDC7ACHE
SCHEMBL6531233 0.90 GSK3B (0.57) GSK3BCDK1CDK2CDC7AURKB
SCHEMBL2337764 0.89 GSK3B (0.60) GSK3BCDK1CDK2AURKBAPP
SCHEMBL1377267 0.88 GSK3B (0.59) GSK3BCDK1CDK2CDC7ACHE
SCHEMBL2338648 0.83 GSK3B (0.58) GSK3BCDK1CDK2CDC7APP
SCHEMBL1375621 0.80 GSK3B (0.64) GSK3BCDK1CDK2CDC7APP
SCHEMBL1377239 0.78 GSK3B (0.54) GSK3BCDK1CDK2CDC7ACHE
SCHEMBL1378947 0.77 GSK3B (0.70) GSK3BCDK1CDK2CDC7ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4764168-B2 2011-08-31 JP claimed
EP-1572200-A1 AMINOINDAZOLE DERIVATIVES AND USE THEREOF AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-09-14 EP claimed
WO-2004062662-A1 AMINOINDAZOLE DERIVATIVES AND USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-07-29 WO claimed